3p22.1 and 10q22.3 Deletions Detected by Fluorescence In Situ Hybridization (FISH): A Potential New Tool for Early Detection of Non-small Cell Lung Cancer (NSCLC)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Thoracic Oncology

• Publication date

  2008-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/JTO.0b013e3181834f3aPMID 18758299PMCID PMC3370669
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CT screening for lung cancer is justified

  2008cited by this paper
• Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer

  2008cited by this paper
• CT screening for lung cancer is justified

  2007cited by this paper
• Survival of Patients with Stage I Lung Cancer Detected on CT Screening

  2007cited by this paper
• Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size.

  2006cited by this paper
• Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology.

  2006cited by this paper
• Survival of patients with stage I lung cancer detected on CT screening.

  2006cited by this paper
• A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.

  2006cited by this paper
• Survival of Patients with Stage I Lung Cancer Detected on CT Screening The International Early Lung Cancer Action Program Investigators

  2006cited by this paper
• Surfactant Protein A Gene Deletion and Prognostics for Patients with Stage I Non–Small Cell Lung Cancer

  2005cited by this paper
• Combined status of MUC1 mucin and surfactant apoprotein A expression can predict the outcome of patients with small‐size lung adenocarcinoma

  2004cited by this paper
• Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo

  2004cited by this paper
• Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations

  2004cited by this paper
• Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer.

  2004cited by this paper
• Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

  2004cited by this paper
• Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization.

  2003cited by this paper
• Sputum cytology for the detection of early lung cancer.

  2003cited by this paper
• Use of Interphase Fluorescence In Situ Hybridization as a Powerful Diagnostic Tool in Cytology

  2002cited by this paper
• FHIT as Tumor Suppressor: Mechanisms and Therapeutic Opportunities

  2002cited by this paper
• Molecular approaches to lung cancer evaluation.

  2002cited by this paper
• Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers

  2002cited by this paper
• How many tumor suppressor genes are involved in human lung carcinogenesis?

  1999cited by this paper
• Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy.

  1998cited by this paper
• Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line.

  1988cited by this paper
• The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10

  1987cited by this paper
• Some results of screening for early lung cancer

  1981cited by this paper

• Promoter Hyper-methylation of ZNF662 Restrains its Tumor Suppressing Function in Triple-Negative Breast Cancer Through Regulating NGF Signaling Axis

  2025cites this paper
• Non-invasive detection of orthotopic human lung tumors by microRNA expression profiling of mouse exhaled breath condensates and exhaled extracellular vesicles

  2024cites this paper
• The diagnostic value of circulating abnormal cells in early lung cancer.

  2023cites this paper
• The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules

  2023cites this paper
• Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules

  2022cites this paper
• Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.

  2020cites this paper
• Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer

  2020cites this paper
• Non-invasive early detection of malignant pulmonary nodules by FISH-based sputum test.

  2018cites this paper
• Copy number variation in archival melanoma biopsies versus benign melanocytic lesions

  2016cites this paper
• FANCJ is essential to maintain microsatellite structure genome-wide during replication stress

  2016cites this paper
• FANCJ is essential to maintain microsatellite structure genome-wide during replication stress

  2016cites this paper
• Distinguishing Melanocytic Nevi from Melanoma by DNA Copy Number Changes: Array-Comparative Genomic Hybridization as a Research Tool

  2015cites this paper
• Development of a multivariate model to predict the likelihood of carcinoma in patients with indeterminate peripheral lung nodules after a nondiagnostic bronchoscopic evaluation.

  2014cites this paper
• Ex vivo chemical cytometric analysis of protein tyrosine phosphatase activity in single human airway epithelial cells.

  2014cites this paper
• Molecular biology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cites this paper
• [Allelic imbalance in patients with non-small cell lung cancer].

  2013cites this paper
• Measurement of protein tyrosine phosphatase activity in single cells by capillary electrophoresis.

  2013cites this paper
• Genome-Wide Association Study of Prognosis in Advanced Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

  2012cites this paper
• A potential probe set of fluorescence in situ hybridization for detection of lung cancer in bronchial brushing specimens

  2012cites this paper
• Molecular cytogenetic evidence for multistep tumorigenesis: Implications for risk assessment and early detection

  2011cites this paper
• Genetic and epigenetic changes in lung carcinoma and their clinical implications

  2011cites this paper
• Genetically Abnormal Circulating Cells in Lung Cancer Patients: An Antigen-Independent Fluorescence In situ Hybridization–Based Case-Control Study

  2010cites this paper
• Computerized analysis of cytology and fluorescence in situ hybridization (FISH) in induced sputum for lung cancer detection

  2010cites this paper
• New biomarkers for lung cancer.

  2010influential citation
• Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens.

  2010cites this paper
• Reclassifying bronchial-pulmonary carcinoma: differentiating histological type in biopsies by immunohistochemistry.

  2009cites this paper
• Artigo de Revisão Review Article

  2009cites this paper
• Reclassificação do carcinoma broncopulmonar: Diferenciação do tipo histológico em biópsias por imuno-histoquímica

  2009cites this paper